Moderna announces first participant dosed in phase 2 study of omicron-specific booster candidate and publication of data on booster durability against omicron variant
Phase 2 study of omicron-specific booster candidate ( mrna-1273.529) will include two cohorts: one including participants who received the two-dose primary series of mrna-1273 and another including participants who received the two-dose primary series and a 50 Μg booster dose of mrna-1273 omicron neutralization six months after the third 50 Μg dose of mrna-1273 declined, but remained detectable in all participants cambridge, ma / accesswire / january 26, 2022 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced that the first participant has been dosed in the phase 2 study of the company's omicron-specific booster candidate (mrna-1273.529). additionally, moderna announced the publication of neutralizing antibody data against the omicron variant six months following a booster dose in the new england journal of medicine.
MRNA Ratings Summary
MRNA Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission